Dhvanit Shah, PhD

Dhvanit Shah is the Founder, President, and CEO of Garuda Therapeutics, which seeks to eliminate the dependency on donor or patient cells for blood stem cell transplants entirely. Prior to founding Garuda, Dhvanit previously served as Principal Faculty of Harvard Stem Cell Institute, Associate Member of the Broad Institute of MIT and Harvard, and Principal Investigator at Brigham and Women’s Hospital.

Dhvanit received his Ph.D. in Pharmacology & Toxicology/Medicine from Punjabi University and completed his Post-Doctoral Fellowship at Harvard Medical School.